Cargando…
Efficacy and safety of triple versus dual antithrombotic therapy in atrial fibrillation and ischemic heart disease: a systematic review and meta-analysis
The optimal antithrombotic regimen for patients with atrial fibrillation and ischemic heart disease remains unclear. Therefore, we aimed to compare the efficacy and safety of triple therapy (TT [an anticoagulant and 2 antiplatelet drugs]) with dual therapy (DAPT [2 antiplatelet drugs] or DT [an anti...
Autores principales: | Zhu, Wengen, Guo, Linjuan, Liu, Fadi, Wan, Rong, Shen, Yang, Lip, Gregory Y.H., Hong, Kui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655270/ https://www.ncbi.nlm.nih.gov/pubmed/29113375 http://dx.doi.org/10.18632/oncotarget.20870 |
Ejemplares similares
-
Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis
por: Wang, Cen, et al.
Publicado: (2017) -
Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials
por: Golwala, Harsh B, et al.
Publicado: (2018) -
Meta-analysis of postoperative antithrombotic therapy after left atrial appendage occlusion
por: Li, Shu-yue, et al.
Publicado: (2020) -
Impact of hyperlipidemia and atrial fibrillation on the efficacy of endovascular treatment for acute ischemic stroke: a meta-analysis
por: Zheng, Jingwei, et al.
Publicado: (2017) -
Prophylactic Atrial Fibrillation Ablation in Atrial Flutter Patients without Atrial Fibrillation: A Meta-Analysis with Trial Sequential Analysis
por: Xie, Xinxing, et al.
Publicado: (2018)